Skin ultrasound has shown promising results in the evaluation of skin involvement in patients with systemic sclerosis, as substantiated by a recent systematic literature review from the World Scleroderma Foundation Skin Ultrasound Working Group. In this Viewpoint, we will discuss the role of ultrasound in evaluating skin involvement in patients with systemic sclerosis, particularly the possibility of using this technique to detect an early subclinical skin involvement from the very early phase, suggesting its possible use in both diagnosis and disease follow-up. To detect subclinical skin involvement, it is essential to understand the difference between the skin of patients with systemic sclerosis and that of healthy controls, including defining exactly which structures are affected by the disease and which are spared. The potential of this non-invasive technique might suggest its future role in both clinical practice and clinical trials, possibly replacing invasive and painful procedures such as skin biopsies and promoting patient retention in clinical trials.

The role of skin ultrasound in systemic sclerosis: looking below the surface to understand disease evolution / Lepri, G.; Hughes, M.; Allanore, Y.; Denton, C. P.; Furst, D. E.; Wang, Y.; Santiago, T.; Galetti, I.; Del Galdo, F.; Khanna, D.; Matucci Cerinic, M.. - In: THE LANCET. RHEUMATOLOGY. - ISSN 2665-9913. - 5:7(2023), pp. 422-425. [10.1016/S2665-9913(23)00100-5]

The role of skin ultrasound in systemic sclerosis: looking below the surface to understand disease evolution

Matucci Cerinic M.
Ultimo
2023-01-01

Abstract

Skin ultrasound has shown promising results in the evaluation of skin involvement in patients with systemic sclerosis, as substantiated by a recent systematic literature review from the World Scleroderma Foundation Skin Ultrasound Working Group. In this Viewpoint, we will discuss the role of ultrasound in evaluating skin involvement in patients with systemic sclerosis, particularly the possibility of using this technique to detect an early subclinical skin involvement from the very early phase, suggesting its possible use in both diagnosis and disease follow-up. To detect subclinical skin involvement, it is essential to understand the difference between the skin of patients with systemic sclerosis and that of healthy controls, including defining exactly which structures are affected by the disease and which are spared. The potential of this non-invasive technique might suggest its future role in both clinical practice and clinical trials, possibly replacing invasive and painful procedures such as skin biopsies and promoting patient retention in clinical trials.
2023
HIGH-FREQUENCY ULTRASOUNDCLINICAL-TRIALSSCOREINVOLVEMENTTHICKNESS
File in questo prodotto:
File Dimensione Formato  
The role of lung biopsy for diagnosis and prognosis of interstitial lung disease in systemic sclerosis a systematic literature review.pdf

accesso aperto

Tipologia: PDF editoriale (versione pubblicata dall'editore)
Licenza: Creative commons
Dimensione 1.36 MB
Formato Adobe PDF
1.36 MB Adobe PDF Visualizza/Apri

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/20.500.11768/181757
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus 7
  • ???jsp.display-item.citation.isi??? 7
social impact